Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic efficacy study of four artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria in Nigerian children
PACTR202609617254072Phase 4Recruiting
- Sponsor
- National Malaria Elimination Programme
- Start
- Jul 2026
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether, lumefantrine, artesunate, amodiaquine, dihydroartemisinin and 2 more in Malaria (4 arms), sponsored by National Malaria Elimination Programme. Primary endpoint: PCR-corrected adequate clinical and parasitological response. Started Jul 2026; status: recruiting.
02
Drugs
artemetherlumefantrineartesunateamodiaquinedihydroartemisinin
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202609617254072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609617254072.